In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

An ICMR-funded trial led by CMC Vellore demonstrated that CAR-T therapy, which uses a patient’s own T cells to fight cancer, can be safely manufactured at the hospital and infused to treat patients in ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.